American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 809 | 14,059 | 12,475 | 8,236 | 3,118 |
| Depreciation Amortization | 3,376 | 13,633 | 10,386 | 6,977 | 3,472 |
| Income taxes - deferred | -117 | -403 | -508 | -43 | 6 |
| Accounts receivable | 33,783 | -25,708 | -22,639 | -9,346 | 3,995 |
| Accounts payable and accrued liabilities | 781 | 2,017 | 4,078 | 3,850 | 3,163 |
| Other Working Capital | 16,275 | -23,386 | -18,176 | -9,025 | -1,378 |
| Other Operating Activity | -33,304 | 27,999 | 21,718 | 7,092 | -6,612 |
| Operating Cash Flow | $21,603 | $8,212 | $7,335 | $7,740 | $5,763 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,784 | -6,063 | -5,358 | -1,365 | -1,090 |
| Purchase Of Investment | -19 | -54 | -21 | -11 | -12 |
| Purchase Sale Intangibles | N/A | -18 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -224 | -29 | -34 | -20 |
| Investing Cash Flow | $-5,803 | $-6,341 | $-5,408 | $-1,410 | $-1,122 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 6,765 | N/A | N/A | N/A |
| Debt Issued | 759 | N/A | 6,765 | 4,543 | 821 |
| Debt Repayment | -778 | N/A | -10,613 | -6,142 | N/A |
| Other Financing Activity | 0 | -10,635 | 0 | 0 | -842 |
| Financing Cash Flow | $-20 | $-3,870 | $-3,848 | $-1,599 | $-22 |
| Exchange Rate Effect | 1,084 | 5,442 | 3,252 | 577 | 42 |
| Beginning Cash Position | 94,569 | 91,127 | 91,127 | 91,127 | 91,127 |
| End Cash Position | 111,433 | 94,569 | 92,457 | 96,434 | 95,787 |
| Net Cash Flow | $16,864 | $3,442 | $1,330 | $5,307 | $4,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,603 | 8,212 | 7,335 | 7,740 | 5,763 |
| Capital Expenditure | -5,784 | -6,063 | -5,358 | -1,365 | -1,090 |
| Free Cash Flow | 15,819 | 2,148 | 1,977 | 6,375 | 4,673 |